SAPCD2 and fibrosarcoma: In this study, our results showed that SAPCD2 is dramatically upregulated in clinical fibrosarcoma tissues, and this upregulation is significantly correlated with early progression and metastasis, and poor overall prognosis in fibrosarcoma patients.